Drugs / iNSC
last change Mar 2019 re-read 3 minutes ago

iNSC

Cell therapy

Developed for
ischemic stroke
Investigated by
Allife Medical Science and Technology Co., Ltd.

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT03725865 Mar 2019 ischemic stroke Allife Medical Science and Technology Co., Ltd. Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as iNSC “Brain injection iNSC” NCT03725865 ↗
Modality Cell therapy “induction of neural stem cells transplantation in the brain” NCT03725865 ↗
Route Other “Brain injection iNSC” NCT03725865 ↗